Coronavirus (COVID-19)

COVID-19 vaccine and booster requirements

All students who have a physical presence on campus are required to complete a primary series of COVID-19 vaccines. All Binghamton University students must upload proof of having received a complete COVID-19 vaccine series before moving into residence halls. Students with in-person classes must do the same before they are able to complete course registration. Details on what constitutes a primary vaccine series and how to upload proof are available on the vaccinations webpage.

In limited circumstances, students may apply for a medical or religious exemption from the COVID-19 vaccine requirement.

Only students who have symptoms consistent with COVID-19 or who need a test five days after being in close contact of someone with diagnosed with COVID-19, are eligible to be tested at the DSHSC. Options for scheduling an appointment are on the diagnostic testing webpage.

The University no longer requires masking, except for individuals in healthcare facilities (e.g., Decker Student Health Services (DSHSC), University Counseling Center, Surveillance Testing Center).

Binghamton University will not require students to be tested for COVID-19 upon arrival on campus for the fall 2022 semester.

View the full fall 2022 guidance online.


Accessing medical care

If you feel ill, do not leave your on-campus room or come to campus if you are an off-campus residing student.

  • It is recommended that all students with symptoms of COVID-19, even mild or minimal ones, should isolate themselves and get a diagnostic test.
  • With the new SARS-CoV-2 variants, a single negative test early in the course of the illness may not be reliable. Students with symptoms and a negative home test should consider making an appointment with provider at the DSHSC via the patient portal
  • If Decker is closed, and you are experiencing symptoms, more information about local health facilities with after-hours care is available on the diagnostic testing page.
  • Students are responsible for the potential cost of COVID-19 testing.